We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Varian Medical Systems

Provides solutions for advancing cancer treatment, radiosurgery, X-ray imaging, & security, radiotherapy, radiosurger... read more Featured Products: More products

Download Mobile App




Anchored Beacon Transponder Guides Lung Cancer Radiotherapy

By HospiMedica International staff writers
Posted on 01 May 2018
A novel beacon transponder detects even slight movements of a tumor, helping clinicians deliver lung stereotactic body radiotherapy (SBRT) more precisely.

The Varian Medical Systems (Varian; Palo Alto, CA, USA) Calypso Anchored Beacon Transponder is designed for implantation in small airways within or near the tumor target. More...
Anchoring is provides via five expandable nitinol legs that provide stable fixation, preventing the transponder from moving. Once in place, the transponder emits continuous, non-ionizing electromagnetic signals that are tracked in real-time and used to keep a SBRT beam on target. The Anchored Beacon transponder is intended for use with the Varian TrueBeam, Edge, and Clinac C-series medical linear accelerators.

The direct internal tracking eliminates the need for external surrogates to track tumor motion in real time, so that high-dose lung SBRT can be delivered with reduced margins between the clinical target volume (CTV) and the planning target volume (PTV). The implantation process itself is straightforward, similar to a lung biopsy, using a pre-loaded, single use delivery catheter designed for interventional pulmonologists and general pulmonologists with advanced bronchoscopy training. The Calypso Anchored Beacon Transponder has been approved by the U.S. Food and Drug Administration (FDA).

“The 510(k) clearance of the Anchored Beacon Transponder expands the application of the Calypso system platform,” said Ed Vertatschitsch, vice president of global portfolio solutions at Varian. “Using the Calypso system and Anchored Beacon transponder, clinicians can deliver dose to lung tumors with increased confidence and accuracy.”

SBRT is emerging as an attractive option for treating cancers in the lung, head and neck, prostate, liver and other disease sites, with the objective of increasing local control of the target lesion while limiting damage to nearby critical structures and normal tissue. Requirements include precise localization of the target lesion in the treatment planning process; accounting for tumor motion due to respiration or other changes in the body; highly conformal dose distribution to the target volume, including a steep dose gradient to minimize radiation to surrounding healthy tissue; and image-guidance at the time of dose delivery for verification and adjustment of the target localization.


Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Biochip Array Technology
Evidence MultiSTAT Drugs of Abuse Urine Multiplex Panel
Digital Radiography System (Ceiling Free)
Digix CF Series
POC Respiratory/Sore Throat Test
BIOFIRE SPOTFIRE (R/ST) Panel
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: Graphical Abstract (Aoibhin M. Sheedy et al., A replenishable peritoneal implant for localized delivery and peritoneal fluid sampling in ovarian cancer, Device (2026). DOI: 10.1016/j.device.2026.101050)

New Implant Provides Sustained Localized Therapy for Ovarian Cancer

Ovarian cancer is often diagnosed at advanced stages because symptoms such as bloating, pain, and pelvic pressure are nonspecific. Standard care relies on surgery and systemic therapy, yet tools for targeted... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.